Endologix to Present at the 2011 Bank of America Merrill Lynch Health Care Conference

IRVINE, Calif., May 6, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the 2011 Bank of America Merrill Lynch Health Care Conference in Las Vegas, NV.

Event:	2011 Bank of America Merrill Lynch Health Care Conference
Date:	Tuesday, May 10, 2011
Time:	3:40 p.m. PT

An audio Web cast of the Company's presentation will be available by visiting the investor relations section of Endologix's Web site at www.endologix.com.  A replay of the presentation will be available for 30 days.

About Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's flagship product is the Powerlink® System, which is an endovascular stent graft for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.com.

COMPANY CONTACT:	INVESTOR CONTACTS:
Endologix, Inc.	The Ruth Group
John McDermott, CEO	Nick Laudico [phone]
[phone]	Zack Kubow [phone]
www.endologix.com

SOURCE Endologix, Inc.

Copyright 2011 PR Newswire